Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$724.0M
+7.3% from 2023
Prescriptions
27K
$26,569.05 per claim
Patients
2,728
604 prescribers
Total spending, 2024
$724.7M
$265,266.91 per patient
Medicare prescription drug plans paid $724.0M for Trikafta in 2024, for 27,249 prescriptions and refills to 2,728 patients (up 7.3% from 2023). The average cost per claim was $26,569.05.
Florida had the highest Medicare cost for Trikafta in 2024: $51.3M for 1,933 claims, followed by Ohio ($41.9M).
Joseph Pilewski, pulmonary disease in Pittsburgh, PA, had the highest Medicare cost for Trikafta in 2024: 498 claims costing $13.4M.
Trikafta is made by Vertex Pharmaceuticals Incorporated (VRTX), listed in the Medicare spending data as Vertex Pharmace.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Joseph Pilewski Pittsburgh, PA | Pulmonary Disease | 498 | 51 | $13.4M |
| Daniel T Layish Orlando, FL | Pulmonary Disease | 475 | 45 | $13.0M |
| James J Tolle |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 570 | 23,953 | 2,485 | $646.9M |
| 2023 | 591 | 24,610 | 2,533 | $674.5M |
| 2024 | 604 | 27,249 | 2,728 | $724.0M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Allergy/ Immunology |
| 385 |
| 38 |
| $9.6M |
| Jana B Yeley Indianapolis, IN | Nurse Practitioner | 385 | 38 | $9.6M |
| Jerry A Nick Denver, CO | Pulmonary Disease | 313 | 34 | $8.4M |
| Milene Saavedra Denver, CO | Critical Care (Intensivists) | 298 | 32 | $8.3M |
| Daniel B Rosenbluth Saint Louis, MO | Pulmonary Disease | 312 | 31 | $8.3M |
| Chakrapol Sriaroon Tampa, FL | Pulmonary Disease | 324 | 41 | $8.1M |
| William R Hunt Atlanta, GA | Pulmonary Disease | 284 | 38 | $7.3M |
| Dana P Albon Charlottesville, VA | Pulmonary Disease | 280 | 27 | $7.3M |
| Maria G Tupayachi Ortiz Miami, FL | Internal Medicine | 232 | 25 | $6.2M |
| Jonathan B Zuckerman South Portland, ME | Pulmonary Disease | 218 | 25 | $5.5M |
| Mary-Katherine Wainwright Birmingham, AL | Nurse Practitioner | 214 | 32 | $5.4M |
| Jorge E Lascano Gainesville, FL | Critical Care (Intensivists) | 196 | 30 | $5.2M |
| Jennifer M Stark Hammond, LA | Nurse Practitioner | 192 | 16 | $5.1M |
| Kimberly A McBennett Cleveland, OH | Pediatric Medicine | 189 | 23 | $5.0M |
| Holly J Carveth Salt Lake City, UT | Pulmonary Disease | 188 | 22 | $4.9M |
| Jill D Fliege Omaha, NE | Nurse Practitioner | 198 | 21 | $4.8M |
| Angela R Oder Cincinnati, OH | Nurse Practitioner | 178 | 19 | $4.6M |
| Jeffrey B Hoag Philadelphia, PA | Pulmonary Disease | 165 | 15 | $4.5M |
| Nathan Garrett Lexington, KY | Nurse Practitioner | 177 | 31 | $4.5M |
| Michael I Anstead Lexington, KY | Pulmonary Disease | 179 | 28 | $4.5M |
| Virginia M Satcher Portland, OR | Nurse Practitioner | 175 | 19 | $4.4M |
| Meredith N Wiltsie Stanford, CA | Nurse Practitioner | 165 | 22 | $4.3M |
| Ashley E Nance Columbus, OH | Nurse Practitioner | 146 | 29 | $4.2M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Vertex Pharmace VRTX | 27,275 | $724.7M |